Silexion Therapeutics
(NASDAQ) SLXN
Silexion Therapeutics Financials at a Glance
Market Cap
$2.91MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$12.91M
EPS (TTM)
-$94.56
P/E Ratio
-0.03
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Price
$2.59
Volume
154
Open
$2.59
Price
$2.59
Volume
154
Open
$2.59
Previous Close
$2.74
Daily Range
$2.59 - $2.59
52-Week Range
$2.31 - $223.60
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Price
$2.59
Volume
154
Open
$2.59
Previous Close
$2.74
Daily Range
$2.59 - $2.59
52-Week Range
$2.31 - $223.60
Estimated Earnings Date
Aug 11, 2026
SLXN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Silexion Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
14
CEO
Ilan Hadar, MBA
Website
silexion.comHeadquarters
Jerusalem, 9112001, IL
SLXN Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-516.87%
Return on Capital
378.77%
Return on Assets
-280.53%
Earnings Yield
-33.33%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.91MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
1.06M
Volume
154
Avg. Volume
638.57K
Financials (TTM)
Gross Profit
-$6.00K
Operating Income
$10.53M
EBITDA
-$12.89M
Operating Cash Flow
-$12.01M
Capital Expenditure
-$3.00K
Free Cash Flow
-$12.02M
Cash & ST Invst.
$2.41M
Total Debt
$436.00K
Silexion Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$2.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$2.91MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$208.06K
N/A
Employees
14
N/A
Net Income
-$2.73M
-57.5%
EBITDA
-$2.73M
-58.6%
Quarterly Fundamentals
Total Cash
$2.41M
-60.8%
Total Debt
$436.00K
-87.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$251.00K
-92.5%
Short Term Debt
$185.00K
+19.4%
Return on Assets
-2.81%
N/A
Return on Invested Capital
19.43%
N/A
Free Cash Flow
-$3.65M
-48.3%
Operating Cash Flow
-$3.65M
-48.6%